UK advisors back Moderna’s bivalent shot for autumn COVID booster
The UK’s Joint Committee on Vaccinations and Immunisations (JCVI) has said that Moderna’s bivalent COVID-19 vaccine should be used for the autumn booster campaign in […]
Covid-19 Vaccine
US government buys 66m doses of Moderna’s Omicron booster
The Biden administration has confirmed its plans to start a booster vaccination campaign in the autumn, and placed a $1.74 billion order for 66 million […]
Pfizer takes COVID jab with ‘enhanced’ spike protein into phase 2
Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that […]
CDC panel gives green light to Novavax COVID-19 vaccine
A Centers for Disease Control and Prevention (CDC) advisory committee on Tuesday unanimously voted to recommend the Novavax COVID-19 vaccine, giving a green light to […]
EU watchdog formally reprimands Commission over Pfizer texts
The European Commission’s failure to reveal text messages between president Ursula von der Leyen and Pfizer chief executive Albert Bourla on COVID-19 vaccine procurement has […]
Fauci: Take new subvariant seriously, but don’t ‘let it disrupt our lives’
Anthony Fauci, the government’s top infectious disease expert, said Tuesday that a new omicron subvariant on the rise is something to take seriously but should […]
BioNTech bites back after CureVac patent challenge
BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will “vigorously” defend itself. CureVac […]
Pfizer claims new $3.2bn COVID jab deal with US government
Pfizer and BioNTech have signed a new $3.2 billion supply contract with the US government for COVID-19 vaccines, covering 105 million doses that may include […]
US panel backs Omicron-targeting vaccines for booster campaigns
Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according to the FDA’s Vaccines and Related Biological […]
Moderna says COVID booster works against Omicron subvariants
Moderna has reported top-line data suggesting that its COVID-19 booster vaccine candidate stimulates a strong immune response against the Omicron subvariants BA.4 and BA.5, which […]
FDA advisors back COVID jabs for very young children
The FDA’s vaccines advisors have voted in favour of extending the use of mRNA-based COVID-19 vaccine from Moderna and Pfizer/BioNTech to include children from the […]
Moderna says new bivalent COVID-19 vaccine tops Spikevax
Moderna’s new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company’s original Spikevax shot in a head-to-head clinical […]
Covid-19 roundup: Boosters for kids, CAR-NK cell therapy, Paxlovid rebound & more
Pfizer and BioNTech reported positive clinical data for a Covid-19 booster in children younger than 5, results released ahead of a June FDA advisory committee […]
COV-BOOST trial data show value of fourth dose
Administering a fourth dose of an mRNA COVID-19 vaccine provides a stronger level of protection than a third dose, particularly in the over-70s, according to […]
Moderna unveils first clinical data on bivalent COVID variant booster
Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, […]
Covid news roundup: Boosters for kids, breath diagnostic, a vax approval & more
Pfizer and BioNTech reported preliminary clinical data supporting use of their Covid-19 vaccine as a booster in children ages 5 to 11. In other Covid […]
EU says not enough evidence to warrant fourth COVID jabs
It is too early to consider widespread use of a second COVID-19 vaccine booster dose, according to the European Centre for Disease Prevention and Control […]
CureVac and GSK try again with COVID-19 vaccine
CureVac and GlaxoSmithKline’s first attempt to develop a COVID-19 vaccine was a salutary reminder of the pitfalls in drug development, as the mRNA shot crashed […]
Moderna follows Pfizer in asking FDA for second COVID booster okay
Moderna has asked the FDA for emergency use authorisation for a fourth dose of its mRNA COVID-19 vaccine SpikeVax, following in the footsteps of Pfizer/BioNTech […]
The (sort of, partial) Father mRNA Vaccines Who Now Spreads Vaccine Misinformation (Part 2)
By DAVID WARMFLASH, MD This is part 2 of David Warmlash’s takedown of Robert W. Malone’s appearance (transcript) on the Rogan podcast. Part 1 is […]
The (sort of, partial) Father mRNA Vaccines Who Now Spreads Vaccine Misinformation (Part 1)
By DAVID WARMFLASH, MD Robert W. Malone, MD MS, is a physician-scientist who will live in infamy, thanks to the Joe Rogan Experience Podcast boosting […]
Alnylam sues Pfizer, Moderna over COVID-19 vaccines
Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their mRNA-based COVID-19 vaccines, because they are both […]
Pfizer makes case for fourth COVID jab dose to FDA
Earlier this week, Pfizer chief executive Albert Bourla said that a second booster of its COVID-19 vaccine will be necessary to keep the pandemic under […]
COVID vaccines not linked to excess deaths, says CDC
There is no evidence that vaccination with either the Pfizer/BioNTech or Moderna’s mRNA-based COVID-19 vaccines led to the death of patients, says a study by […]
COVID jabs now offered to all children aged 5 to 11 across UK
England and Northern Ireland have followed Wales and Scotland in offering healthy children aged between five and 11 a low-dose COVID-19 vaccine, making vaccination an […]
AZ halts development of Beta variant COVID-19 vaccine
AstraZeneca confirmed today that it has discontinued clinical development of a follow-up to its COVID-19 vaccine Vaxzevria targeted at the Beta variant of the virus, […]
Novavax COVID jab ‘could save UK money on boosters’
The approval of Novavax’ COVID-19 vaccine in Great Britain could help the country save a “considerable amount of money” if it is used in future […]
The Social Science of Covid
By MIKE MAGEE As we enter the third year of the Covid pandemic, with perhaps a partial end in sight, the weight of the debate […]
Digital innovation drives vaccine development
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they […]
Daiichi makes play for share of Japan’s COVID booster market
Daiichi Sankyo has stepped up its efforts to bring a Japanese COVID-19 vaccine to patients, starting a new clinical trial of its mRNA-based candidate DS-5670 […]
EC criticised in probe of COVID vaccine texts with Pfizer CEO
The failure of the European Commission to locate text messages between its president Ursula von der Leyen and Pfizer chief executive Albert Bourla on procurement […]
Moderna starts dosing patients with its Omicron COVID jab
Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost […]
Pfizer starts dosing patients with its Omicron COVID shot
Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against […]
The Covid Vaccine’s PR Crisis: Health Innovation vs the Take-Down Power of Disinformation
By JESSICA DaMASSA Misinformation and disinformation (intentionally wrong information) have plagued the storyline of the Covid19 vaccine since the early days of its development, creating […]
US Supreme Court blocks Biden’s broad vaccine mandate in 6-3 decision
The US Supreme Court handed down two decisions today relating to COVID-19 vaccine mandates, issuing a stay to prevent a broad mandate from the Occupational […]
Third dose of AZ’s COVID jab boosts Omicron antibodies
Preliminary data from an ongoing trial of AstraZeneca’s COVID-19 vaccine Vaxzevria has shown that a booster dose stimulates an increase in antibodies against Omicron, as […]
Pfizer, Moderna are prepping new vaccines for Omicron
With evidence growing that the current crop of COVID-19 vaccines are less protective against infection with Omicron, both Pfizer and Moderna have announced plans to […]
Gritstone bio trumpets first data for ‘multivariant’ COVID jab
A COVID-19 vaccine that could work against multiple variants of the coronavirus – developed by US biotech Gritstone bio – has generated encouraging immune response […]
FDA clears Pfizer, BioNTech COVID booster for younger teens
The FDA has authorised the first COVID-19 booster vaccine for teenagers in the 12 to 15 age group, giving the okay for wider use of […]
CDC eyes safety of J&J COVID jab as EU backs booster
Johnson & Johnson’s also-ran COVID-19 vaccine has been cleared in the EU as a booster shot, although its role in the US could be impacted […]
Patients ‘29% less likely to be hospitalised with Omicron’
Data from a real-world study South Africa has indicated that the Omicron variant of COVID-19 is 29% less likely to cause hospitalisation among infected adults […]
Booster COVID jabs offered to all adults in England
The UK government has said it will step up its COVID-19 booster vaccination dramatically, with everyone in England aged over 18 offered a third dose […]
Omicron may evade Pfizer/BioNTech COVID jab, says study
Preliminary study results from South Africa have suggested that antibodies stimulated by Pfizer and BioNTech’s Comirnaty are less effective against the new COVID-19 variant Omicron. […]
Omicron set to dominate in UK within weeks, says expert
The Omicron variant could supersede other strains of COVID-19 within the next few weeks to become dominant in the UK, according to an infectious diseases […]
UK government rubberstamps millions of extra COVID vaccines
The UK government has placed a 114 million-dose order with Pfizer/BioNTech and Moderna – sufficient to provide two doses to every person in Britain – in […]
UK accelerates COVID booster plans in response to Omicron
The UK looks set to extend its COVID-19 booster vaccination programme to all over-18s, as the number of cases of the new Omicron variant of […]
Pharma pledges rapid response to Omicron COVID variant
With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said […]
Turkey’s home-grown COVID vaccine project nears fruition
Turkey could have its own COVID-19 vaccine Turkovac available for use by the end of the year, according to the country’s Health Minister Fahrettin Koca. […]
EU authorises first COVID-19 vaccine for 5 to 11 year olds
The European Medicines Agency (EMA) has approved Pfizer and BioNTech’s COVID-19 vaccine Comirnaty for children between the ages of five and 11, as EU countries […]
New COVID variant ‘may sidestep vaccine protection’
A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect […]
FDA, CDC COVID jab decisions ‘will simplify booster messaging’
Three hurdles to allowing booster COVID-19 vaccinations for all adults in the US fell in swift succession on Friday, clearing the way for wider use […]
AstraZeneca will make ‘modest’ profit from COVID vaccine
AstraZeneca has said it plans to start making a small profit from sales of its COVID-19 vaccine Vaxzevria, which brought in just over $1 billion […]
J&J deal with COVAX grants humanitarian access to COVID shot
Johnson & Johnson has reached an agreement to make its one-dose COVID-19 vaccine available to an arm of the COVAX facility that is focusing on […]
Valneva gets EU deal for COVID jab, and may sue UK
Shares in France’s Valneva leaped after it got an EU order to supply 60 million doses of its COVID-19 vaccine VLA2001 over the next two […]
Moderna squares off with US government over COVID jab patent
After being hailed as a triumph of public-private drug development, Moderna’s partnership with the US government on its COVID-19 vaccine looks like it may descend […]
Germany says only Pfizer COVID jab should be used in under 30s
Germany’s vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech’s COVID-19 vaccine Comirnaty, saying it seems less likely to […]
One dose of Regeneron’s COVID antibody protects for eight months
A single dose of the COVID-19 monoclonal antibody therapy developing Regeneron reduced the risk of contracting the virus by around 82% for up to eight […]
US court halts Biden’s COVID shots plan for companies
The US Federal Court of Appeals has issued a temporary stay on President Joe Biden’s plan for mandatory COVID-19 vaccinations for employees of businesses. The […]
Vaccine requirements incoming for healthcare facilities, big businesses
CMS set a deadline for staff at Medicare- or Medicaid- certified facilities to be fully vaccinated against Covid-19 by Jan. 4. Similarly, OSHA is also […]
US backs COVID jabs for young kids – should others follow?
The US is now pressing ahead with plans to extend its COVID-19 vaccination campaign to younger children aged five and over, prompting a debate about […]
Pfizer’s COVID jab sales swell again, with $36bn forecast for 2021
Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once again to a whopping $36 billion, more […]
COVID jabs much more effective than virus at preventing infection
A US study has found that the immunity afforded by COVID-19 vaccines is much stronger than that stimulated by infection with SARS-CoV-2 in unvaccinated individuals. […]
Novavax gets first authorisation for its COVID-19 jab
Novavax has been granted its first emergency use authorisation in Indonesia for COVID-19 vaccine NVX-CoV2373, and expects other regulators in India, the Philippines and other […]
FDA delays review of Moderna COVD jab in adolescents
The FDA has said it needs more time to review Moderna’s application for emergency use of its COVID-19 vaccine mRNA-1273 in children aged 12 to […]
CDC director backs COVID-19 jab for 5 to 11s, plus a fourth shot
The US looks set to see a big expansion of the country’s COVID-19 vaccination drive, with shots looking likely for children aged five to 11 […]
Pfizer and BioNTech’s COVID-19 Vaccine Receive the US FDA’s Advisory Committee Vote Supporting EUA Against COVID-19
Shots: The US FDA’s VRBPAC voted 17 to 0 with 1 abstention in favor of recommending the EUA for COVID-19 vaccine in children aged 5 […]
Moderna Reports Results of COVID-19 Vaccine in P-II/III KidCOVE Study for the Treatment of COVID-19
Shots: The P-II/III KidCOVE study evaluated the safety, tolerability, reactogenicity & effectivity of mRNA-1273 in 4753 children aged 6-12yrs. with COVID-19, administered as 28 days […]
FDA advisors mull use of Pfizer/BioNTech COVID-19 jab in kids
FDA advisors will meet later today discuss the possibility of authorising Pfizer and BioNTech’s COVID-19 vaccine Comirnaty in children as young as five years old. […]
Pfizer and BioNTech Report Results of COVID-19 Vaccine Booster in P-III Trial for the Treatment of COVID-19
Shots: The P-III trial evaluates a booster dose of COVID-19 vaccine (30µg) in a ratio (1:1) in 10000+ individuals aged ≥16yrs. with COVID-19 who previously […]
FDA okays Moderna, J&J COVID jab boosters, plus ‘mix and match’
The FDA has authorised booster shots with Moderna and Johnson & Johnson’s COVID-19 vaccines, a month after giving the go-ahead to a third-dose of Pfizer/BioNTech’s […]
J&J mulls switch from non-profit status for COVID jab
Johnson & Johnson has been offering its COVID-19 vaccine for sale on a no-profit basis since it became available, but is thinking about a possible […]
FDA panel backs booster shot for J&J COVID-19 vaccine
An FDA advisory committee voted unanimously in favour of a booster dose of Johnson & Johnson’s one-shot COVID-19 vaccine on Friday, as panellists suggested it […]
FDA panel supports J&J Covid-19 vaccine booster; no vote on mixing and matching
Johnson & Johnson won the support of an FDA advisory panel, which unanimously recommended a booster shot for adults. The backing comes one day after […]
Moderna unveils $500m plan for African vaccine facility
Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search […]
J&J joins COVID-19 booster shot drive, filing with FDA
Johnson & Johnson’s COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a […]
EU backs broader use of Comirnaty as COVID booster than US
The EMA has given the go-ahead to the use of Pfizer and BioNTech’s COVID-19 vaccine Comirnaty as a booster for all people aged 18 or […]
Novartis tightens up its COVID-19 vaccine policy for staff
Novartis has joined a growing number of companies insisting that its workforce is double vaccinated against COVID-19 if they want to work at one of […]
The Vaccine Brawl – A Legal Battle in Process
By MIKE MAGEE The power to mandate vaccines was litigated and resolved over a century ago. Justice John Marshall Harlin, a favorite of current Chief […]
Sanofi abandons mRNA COVID jab, despite positive trial
Sanofi has said that it won’t develop its mRNA-based vaccine for COVID-19 any further, even though it seemed to work in an early-stage trial, and […]
CDC overrules its advisors, backing COVID booster for health workers
The Centre for Disease Control and Prevention (CDC) in the US has backed booster doses of Pfizer and BioNTech’s COVID-19 vaccine Comirnaty in line with […]
Novavax files its COVID jab to WHO for emergency use listing
Novavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing for their COVID-19 vaccine, based […]
FDA approves Pfizer COVID booster jabs for higher-risk groups
Just days after its advisory committee meeting voted to approve a third dose of Pfizer and BioNTech’s COVID-19 vaccine, the FDA has followed through and […]
Amnesty says COVID jab producers are causing human rights crisis
Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not agreeing to waive their intellectual property rights […]
Pfizer, BioNTech prep low-dose COVID jab filing for kids aged 5 to 11
With positive phase 2/3 results for their COVID-19 vaccine Comirnaty in hand for the five to 11 age group, Pfizer and BioNTech are planning to […]
Pfizer, BioNTech prep low-dose COVID jab filing for kids aged 5 to 11
With positive phase 2/3 results for their COVID-19 vaccine Comirnaty in hand for the five to 11 age group, Pfizer and BioNTech are planning to […]
Ahead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dips
Pfizer and Moderna have both reported data that they say backs up the need for booster shots of their COVID-19 vaccines ahead of an FDA […]
EU ‘negotiating with Valneva’ over COVID-19 vaccine contract
The European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to supply COVID-19 vaccines that was terminated by […]
UK poised to announce booster COVID jabs for over-50s
The UK government is due to announce a large-scale booster vaccine campaign against COVID-19 for all adults aged 50 and over later today, adding to […]
Valneva slumps as UK dumps €1.4bn order for COVID-19 jab
The UK has terminated its order for up to 190 million doses of a COVID-19 vaccine developed by French biotech company Valneva, accusing it of […]
Covid-19 vaccination required for staff in most healthcare settings
CMS, in collaboration with the CDC, is making it mandatory for staff at healthcare facilities participating in Medicare and Medicaid programs to get vaccinated against […]
MHRA clears third doses of AZ, Pfizer COVID jabs
The UK medicines regulator has cleared the use of a third dose of both the AstraZeneca and Pfizer COVID-19 vaccines, in readiness for a possible […]
AZ CEO Soriot urges caution on COVID booster doses
The UK should think twice before backing widespread use of COVID-19 booster vaccinations, as to do so could place unnecessary burden on the NHS over […]
EMA looks at booster data for Pfizer/BioNTech COVID-19 jab
The EU regulator has started to review a marketing application filed by Pfizer and BioNTech for a third, booster dose of their Comirnaty COVID-19 vaccine […]
FDA schedules adcomm for Pfizer’s COVID booster filing
The FDA has said it will hold an advisory committee meeting later this month to discuss Pfizer and BioNTech’s filing for approval of a third […]
GSK takes SK bio-partnered COVID jab into phase 3
As a top vaccine maker, GlaxoSmithKline has been a laggard in the COVID-19 vaccine race, but has put on a late burst of speed with […]
UK real-world study finds COVID-19 jab protection wanes
A study has found evidence that protection from the AstraZeneca and Pfizer/BioNTech COVID-19 vaccines starts fall off after a few months, but a UK government […]
CMS offers additional Medicare payments for at-home Covid-19 vaccinations
Now, Covid-19 vaccine administrators can earn an additional $35 per vaccination for up to five Medicare beneficiaries who live in a communal living space, like […]
Pfizer and BioNTech’s Comirnaty Receive the US FDA’s Approval to Prevent COVID-19 in Individuals Aged 16 Years and Older
Shots: The approval is based on the longer-term follow-up data from the P-III trial that showed high efficacy and favorable safety profile through 6mos. after […]
FDA grants full approval to Pfizer/BioNTech COVID jab
Pfizer and BioNTech’s COVID-19 vaccine was the first to get emergency use authorisation (EUA) from the FDA, and has also become the first to get […]
COVID prompts another milestone, as India clears first DNA vaccine
The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting […]
MHRA clears Moderna COVID vaccine for 12 to 17 year olds
The Moderna COVID-19 vaccine has become the second jab to be authorised for use in England, Scotland and Wales in children aged 12 to 17 […]
Pfizer, BioNTech file for FDA approval of COVID booster shot
Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the […]
FDA authorises COVID booster jabs for at-risk people
The FDA has cleared the use of third dose of either the Pfizer/BioNTech or Moderna COVID-19 vaccines for people with weakened immune systems, but stopped […]
UK cues up more Pfizer/BioNTech vaccines as price row looms
The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third […]
SK Bio’s COVID vaccine will start phase 3 study versus AZ jab
South Korea’s SK Bioscience has been given the all-clear to start a phase 3 trial of its COVID-19 vaccine GBP510 that will compare the shot […]
BioNTech says repeat doses may be better than modified COVID-19 jab
BioNTech has suggested that giving booster doses of its current Comirnaty (BNT162b2) COVID-19 vaccine may be a preferable strategy to modifying the Pfizer-partnered shot. The […]
Moderna COVID-19 jab sales rocket to $4.2 billion in second quarter
Moderna made a massive $4.2 billion from sales of just under 200 million doses of its COVID-19 vaccine, taking its tally since approval to around […]
UK extends COVID vaccination to 16 and 17-year-olds
The UK government has confirmed that the national COVID-19 vaccination campaign will be extended to include 16 and 17-year-old children, to tackle an increase in […]
Germany confirms booster COVID jabs will start in September
Germany’s health ministry has said it will start offering booster COVID-19 vaccines to vulnerable people from next month, amid concerns about rising cases of the […]
AZ’s COVID-19 jab sales top $1.2bn, but come at a loss
AstraZeneca said this morning that it has made $1.2 billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but […]
AZ says second COVID jab dose isn’t linked to rare clot reaction
A new analysis has suggested that the rare blood clot side effects linked to AstraZeneca’s COVID-19 vaccine Vaxzevria don’t occur after a second dose. The […]
First published data backs CanSino’s inhaled COVID vaccine
Early-stage clinical data with CanSino Biologics’ inhaled COVID-19 vaccine show that it was able to stimulate neutralising antibodies against SARS-CoV-2 at a dose well below […]
Study finds jabs cut severe variant COVID disease after one shot
A real-world study carried out in Canada had found that COVID-19 vaccines from AstraZeneca, Pfizer/BioNTech and Moderna reduce the chances of being hospitalised or dying […]
EMA starts review of latecomer GSK/Sanofi COVID-19 vaccine
The EMA has kicked off a rolling review of a COVID-19 vaccine from Sanofi and GlaxoSmithKline, which started a 35,000-patient phase 3 trial in May. […]
UK funds ‘long COVID’ research drive as restrictions ease
The UK government has provided almost £20 million ($27 million) in funding for 15 research projects aiming to look into the causes of long COVID, […]
UK funds ‘long COVID’ research drive as restrictions ease
The UK government has provided almost £20 million ($27 million) in funding for 15 research projects aiming to look into the causes of long COVID, […]
AZ, J&J tweaking COVID shots to reduce clotting risks; report
AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are […]
EMA finds possible link between mRNA COVID jabs and myocarditis
The EU medicines regulator has said that there is some evidence to suggest a possible link between mRNA-based vaccines for COVID-19 and rare cases of […]
Eyeing delta surge, Pfizer will file COVID-19 booster next month
With the COVID-19 delta variant has become the dominant strain circulating in the US, Pfizer and BioNTech have said they will ask the FDA and […]
Israel says Pfizer jab less effective against COVID-19 delta
The Israeli Ministry of Health has reported data suggesting that the efficacy of the Pfizer/BioNTech COVID-19 vaccine has become less effective at preventing the spread […]
Unsure whether to get a COVID-19 jab? Just ask Vira!
With COVID-19 vaccine hesitance an increasing concern in the US, researchers at Johns Hopkins have developed a chatbot – called Vira – that aims to […]
Ocugen preps filings for COVID-19 vaccine Covaxin on new data
Armed with new data from its development partner Bharat Biotech, Ocugen is planning to press ahead with plans to file for approval of their COVID-19 […]
Zydus Cadila nears world-first human plasmid DNA vaccine approval
Zydus Cadila has filed for emergency use approval (EUA) in India of its plasmid DNA-based vaccine for COVID-19, which if given a green light could […]
UK body recommends COVID booster campaign in autumn
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended that the NHS should start a COVID-19 booster shot programme in September, to run […]
UK body recommends COVID booster campaign in autumn
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended that the NHS should start a COVID-19 booster shot programme in September, to run […]
EU and AZ both claim victory in COVID jab supply lawsuit
A court in Belgium has ordered AstraZeneca to deliver additional doses of its COVID-19 vaccine to EU member states by 27 September, although far fewer […]
CureVac hit hard as its COVID jab fails to make the grade
CureVac has just had a harsh reminder of the perilous nature of drug development, after reporting that its mRNA-based COVID-19 vaccine was just 47% effective […]
AZ’s COVID jab tackles delta variant, but antibody fails clinical trial
The delta variant of COVID-19 may be holding back the lifting of lockdown restrictions in the UK, but there is some good news – the […]
Novavax’s COVID-19 Vaccine Demonstrates 90.4% Efficacy in P-III PREVENT-19 Study
Shots: The P-III PREVENT-19 study involves assessing the efficacy, safety, and immunogenicity of NVX-CoV2373 with Matrix-M adjuvant vs PBO in 29,960 participants aged ≥18yrs. across […]
Novavax Covid-19 vaccine shows 90% efficacy, protection against variants
Novavax reported that its Covid-19 vaccine was 100% effective at protecting against moderate and severe disease and 90.4% effective overall. The vaccine is seen as […]
Novavax unveils phase 3 COVID jab data, but has it missed the boat in US?
The top-line phase 3 data for Novavax’ COVID-19 vaccine look good, with a 90% overall efficacy rate, but a dip in its share price indicates […]
J&J must ditch 60m COVID jabs made at US plant, but 10m are okay, says FDA
The failings at a Baltimore, US factory making Johnson & Johnson’s COVID-19 vaccine mean that millions of doses of the shot will have to be […]
Ocugen gets a black eye as FDA denies emergency OK for COVID jab
Ocugen is the first company to be affected by the FDA’s recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and […]
Kaiser Permanente, Centene, others join White House effort to boost vaccination rates
Several organizations, both providers and payers, have pledged to help the White House achieve its goal of administering at least one dose of the Covid-19 […]
US orders 500m Pfizer/BioNTech COVID jabs for developing nations
The US government will buy 500 million more doses of the Pfizer/BioNTech COVID-19 vaccine that will be given to around 100 countries via the COVAX […]
Study links AstraZeneca COVID-19 shot to bleeding disorder ITP
Researchers in Scotland have identified a possible link between the Oxford University/AstraZeneca COVID-19 and a mostly mild and generally treatable bleeding disorder. The scientists examined […]
CMS ups Medicare payment for at-home vaccinations to about $75 per dose
CMS is increasing the payment for administering at-home Covid-19 vaccinations from around $40 to $75 per dose. The move comes amid the Biden administration’s push […]
Millions of COVID jabs risk being wasted, says UNICEF
Rich nations are being asked to start donating COVID-19 vaccines to other parts of the world straight away, to avoid a glut of surplus supply […]
UK is talking to AstraZeneca about beta variant COVID jab
The UK government is talking to AstraZeneca about ordering additional doses of its COVID-19 vaccine that will target the beta variant of SARS-CoV-2 virus first […]
Moderna ramps up EU COVID jab capacity via Lonza deal
Capacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by round 300 million doses a year, following an agreement to set up a […]
100+ workers sue Houston Methodist over mandatory Covid-19 vaccination policy
The lawsuit alleges that the policy is akin to forcing employees to participate in a medical experiment as none of the vaccines available have received […]
Janssen COVID jab cleared in UK as fears of third wave mount
With concern already growing about a possible third wave of COVID-19 infections, the UK has cleared the use of a fourth vaccine from Johnson & […]
Pfizer and BioNTech Receive EC’s Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents
Shots: The approval is based on a P-III study assessing Comirnaty (two 30μg doses) in 2,260 participants aged 12-15yrs. and showed 100% efficacy in participants […]
GSK, Sanofi eye Q4 approval as COVID jab starts phase 3
GlaxoSmithKline’s COVID-19 drive has advanced on two fronts, with the start of phase 3 trials of its Sanofi-partnered vaccine candidate as well as an FDA […]
EU asks court to fine AstraZeneca over missing COVID jab shipments
Lawyers for the European Commission asked a court in Brussels today to fine AstraZeneca millions of euros for its “obvious” failure to meet the terms […]
Belgium halts dosing of J&J COVID vaccine in under 41s after death
Belgium’s Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson’s one-shot COVID-19 vaccine, following the death of […]
Moderna will file COVID-19 jab for teens after trial shows 100% protection
Moderna’s COVID-19 vaccine has joined the Pfizer/BioNTech jab in showing efficacy in younger patients in clinical trials, setting up an emergency use filing early next […]
Pfizer Initiates Study to Evaluate its Pneumococcal Vaccine with Booster dose of its COVID-19 Vaccine
Shots: The first enrolled patient has received their immunizations as part of a new study in adults ≥65yrs. evaluating the coadministration of 20vPnC with a […]
Yes, vaccination will be required to attend HIMSS this year
Two healthcare conferences with in-person events slated for later this year will require people to be vaccinated. HIMSS’ annual conference, which will be held in […]
Pfizer and BioNTech Receive the US FDA’s EMA for COVID-19 Vaccine in Adolescents
Shots: The FDA has expanded the EUA for Pfizer’s COVID-19 vaccine in adolescents based on the data from the P- III trial in 2,260 participants […]
10 Design Considerations for Vaccine Credentials
By ADRIAN GROPPER As COVID-19 vaccines become widely, if not fairly, available in different regions, both the public and private sector are working to develop […]
CVS pilots mental health services in some stores, sees Covid vaccinations slow
After months of frenetic activity to get vaccines to people as quickly as possible, CVS is seeing the number of appointments decline. The retail pharmacy […]
Survey: 42% of Americans may not go back to in-person care this year
Despite the ongoing Covid-19 vaccine rollout, a significant percentage of Americans say they are planning to delay care in 2021 or are unsure about in-person […]
Johnson & Johnson Publishes Results of COVID-19 Single Shot Vaccine in NEJM
Shots: The P-III ENSEMBLE trial involves assessing COVID-19 vaccine vs PBO in 43,783 enrolled participants aged ≥18yrs. with both mod. and sev. COVID-19 disease The […]
Overcoming vaccine hesitancy: How clinicians can promote trust in Covid-19 vaccines
With new viral variants reported across the globe, this evolving pandemic requires clinicians to explore novel ways to assuage patient fears about Covid vaccines.
How AdventHealth is using AI to fight Covid vaccine hesitancy
Vaccine hesitancy is still a challenge to providers’ immunization plans. Florida-based AdventHealth is bringing the might of AI technology — specifically machine learning and natural […]
Cityblock nets another $192M, plans to expand into maternity and pediatrics
The startup, which provides primary care services to Medicaid patients, plans to use the funds to expand into new states and add maternity and pediatrics […]
Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12
Shots: The companies have started testing BNT162b2 in children aged 6-11yrs. with initial results anticipated in H2’21. The companies are planning to expand the vaccination […]
Eric Trump-linked hospital COO reportedly resigns after vaccine controversy
A top executive at Chicago-based Loretto Hospital has resigned after controversy surrounding vaccination events held at businesses with close ties to him. Mayor Lori Lightfoot […]
Communities ask, where is the equity in vaccines?
Areas that have been hit hardest by the Covid-19 pandemic are falling short when it comes to vaccine access. Community leaders are pushing to bring […]
Medicare payment for Covid-19 vaccines jumps to $40-$80
CMS has increased the Medicare payment rate to $40 for administering single-dose Covid-19 vaccines and $80 for two-dose vaccines. The payment increase aims to support […]
UAB Health System CIO: Remote work a boon, and burden, for IT teams
In a wide-ranging interview, UAB Health System CIO Joan Hicks shared some of the projects on her list for the year ahead, and how remote […]
In rebuke of One Medical’s alleged vaccine antics, CA counties sever relationship
Several California counties and Washington state dropped One Medical as a partner in distributing vaccines after reports that it let people who weren’t eligible for […]
Correlative Adventures with COVID
By ANISH KOKA “The patient in room 1 should be a quick one, its an addon, they just need a prescription for ivermectin” I’m a […]
Moderna’s “Secret Sauce”
By MIKE MAGEE This week J&J gained FDA approval for their 1-shot COVID vaccine, leading optimists like Pfizer Board member, Scott Gottlieb, to predict that […]
CMS rule requires insurers to cover tests for asymptomatic patients
A new CMS rule would require insurers to cover Covid-19 tests, even for asymptomatic patients. It builds on previous legislation requiring payers to cover the […]
Clover Biopharma adds $230M as Covid-19 vaccine heads to pivotal test
The protein-based Covid-19 vaccine from Clover Biopharmaceuticals has distribution and storage advantages compared to messenger RNA vaccines. If the vaccine succeeds in a Phase 2/3 […]
Stamford Health wants to vaccinate 3,000 people a day. Here’s how
Stamford Health has partnered with city and state officials and community organizations to execute its Covid-19 vaccine administration plans. The health system has ambitious plans […]
CVS plans to re-enter ACA marketplace in 2022
After completely exiting the ACA exchanges in 2018, CVS plan to re-enter them in 2022. Last year, enrollment through federal exchanges increased, and Aetna CEO […]
Beaumont shuts down Covid-19 vaccination scheduling for nearly 24 hours after breach
An unknown user publicly shared a link to access Beaumont’s Epic-enabled vaccination scheduling services, which resulted in 2,700 people making unauthorized appointments for a Covid-19 […]
Johnson & Johnson Report Results from P-III ENSEMBLE Trial for COVID-19 Vaccine
Shots: The P-III ENSEMBLE trial to evaluate the efficacy and safety of Janssen’s COVID-19 vaccine candidate in protecting mod-to-severe COVID-19 in 43,783 participants accruing 468 […]
The provider’s IT playbook for efficient, equitable Covid-19 vaccine distribution
The vaccine distribution process has begun and providers are figuring out how to make sure the doses are administered quickly, equitably and in a coordinated […]
Merck drops out of the Covid-19 vaccine race after subpar data
Merck is discontinuing development of its two Covid-19 vaccine candidates. Instead, it plans to focus on two therapeutic candidates for the disease.
Searching for vaccine information? Google wants to make it easier to find
As states begin to roll out vaccines to the broader public, Google will make it easier for people to find out when they are eligible […]
Report: ‘Pharmacy deserts’ may significantly hinder vaccine rollout
Like food deserts, pharmacy deserts have cropped up across the nation, which could further hamper the much-maligned Covid-19 vaccine rollout.
COVID-19 Vaccine: What to Expect with the Vaccine and Everything Else about it?
Finally, the End is Near!!! I am not talking about THE end of the world but an end to our struggles with the deadly COVID-19 […]
Kaiser Permanente to analyze CDC’s Covid-19 vaccine data, identify bad reactions
The CDC has engaged the California-based health system’s Vaccine Study Center to conduct an analysis of its Covid-19 vaccine data with the aim of pinpointing […]
States threaten to crackdown on providers amid Covid-19 vaccine distribution
In an effort to ensure the efficient and orderly distribution of the Covid-19 vaccine, governors from New York, California and Florida are warning that they […]
As new coronavirus strain detected in two states, vaccines fall short
A new variant of SARS-Cov-2 thought to be more transmissible was discovered in Colorado’s eastern plains and San Diego, California. At the same time, federal […]
As new coronavirus strain detected in three states, vaccines fall short
A new variant of SARS-Cov-2 thought to be more transmissible was discovered in Colorado’s eastern plains and San Diego, California. At the same time, federal […]
CVS, Walgreens begin administering first vaccines in nursing homes
CVS and Walgreens began administering the first doses of Covid-19 vaccines across long-term care facilities last week. But many questions still remain about how it […]
Precision measurement in 2021: Why accuracy is key to the vaccine ‘cold chain’ and disrupting the spread of Covid-19
By creating new networks for 24/7 temperature monitoring, alerts and reporting, the challenges of deploying transportation at ultra-low temperatures can be overcome. This also illustrates […]
CO2 Safety Monitors for Dry Ice Vaccination
Ormond Beach, FL – CO2Meter, Inc. has partnered with a national pharmacy chain to keep their customers and employees safe from the potential hazardous effects […]
New COVID vaccines could revolutionize vaccination
The post New COVID vaccines could revolutionize vaccination appeared first on Healthy Debate.
The known unknowns of COVID-19 vaccines
News that COVID-19 vaccines are up to 95 per cent effective has scientists cautiously optimistic. But questions remain. “There’s a long list of things we […]
BioNTech and Pfizer Report CMA Submission of BNT162b2 to EMA for COVID-19
Shots: The companies have submitted CMA to the EMA for BNT162b2, against COVID-19. The submission completes the rolling review process initiated on Oct 6, 2020 […]
BioNTech and Fosun Pharma Initiate P-ll Study of BNT162b2 Against COVID-19 in China
Shots: The companies initiated the P-II study of their COVID-19 vaccine in China. The trial will generate data to support the BLA filing for approval […]
What, Us Worry
By KIM BELLARD 2020 has been an awful year. Hurricanes, wildfires, murder hornets, unjustified shootings, a divisive Presidential election, and, of course, a pandemic. Most […]
Can the Government Mandate a Covid-19 Vaccine? Will It Have To?
By PHILLIP MEYLAN With the emergence of two vaccines with high levels of effectiveness, there’s a strong prospect of having powerful new tools to combat Covid-19 in the […]
J&J and US Government Amends their Agreement for the Next Phase of COVID-19 Vaccine Development
Shots: J&J and the US Department of Health and Human Services have expanded an agreement to support the next phase of COVID-19 vaccine candidate research […]
Novavax Collaborates with Commonwealth of Australia to Supply 40M doses of NVX-CoV2373 for COVID-19
Shots: Novavax has signed a non-binding Heads of Terms document with the Australian Government to supply 40M doses of NVX-CoV2373 for the Australian community The […]
CEPI to Invest ~$328M in Clover’s COVID-19 Vaccine Candidate
Shots: CEPI’s total investment in Clover’s S-Trimer vaccine candidate will be up to $328 M, including $69.5M previously announced have funded preclinical studies and P-l […]
Data hackathon analyses truth behind TB vaccine and COVID-19
Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing […]
COVID-19 biologics will put huge pressure on large-scale bioprocessing networks
Tightening of bio-manufacturing capacity expected to occur after 2024, whilst Europe forecast to equal North America in total capacity Amsterdam: The third part of the 2020 […]
AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan
Shots: The P-I/II study of AZD1222 has resumed in Japan following the discussion with the PMDA. Additionally, the company is in talks with the US […]
Governments have a public health duty to expand vaccination coverage through pharmacies, FIP says
The Hague — Governments and other stakeholders must take urgent action to ensure equity in access to disease prevention measures, which includes greater investment in vaccines […]
2 billion vials. Public acceptance. The obstacles to vaccine delivery
The post 2 billion vials. Public acceptance. The obstacles to vaccine delivery appeared first on Healthy Debate.
COVID-19 vaccines in the making
The post COVID-19 vaccines in the making appeared first on Healthy Debate.
BioNTech and Fosun Pharma to Supply ~10M Doses of COVID-19 Vaccine to Hong Kong and Macao
Shots: BioNTech and Fosun collaborated to supply 10M doses of their BNT162 mRNA-based vaccine candidate against COVID-19 to Hong Kong SAR and Macao SAR, once […]
Moderna’s COVID vaccine works in older people, according to new data
Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in […]
Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology
Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible […]
Moderna Prices its COVID-19 Vaccine at $32-$37 per Dose for Smaller Volume Agreements
Shots: For smaller volume agreements, the company has priced its COVID-19 vaccine ranging from $32-$37/ dose, higher than the price of Pfizer’s vaccine candidate The […]
